Open official notice

Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103

Official notice

11 Nov 2026

Last checked

17 Nov 2026

RecallScope risk estimate:MediumFDA

An official FDA notice concerns Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103. Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis. Published 2026-11-11.

What to do now

Stop using the affected device and follow the corrective action in the official FDA notice. Contact your healthcare provider or the manufacturer for next steps.

Units affected

28,710

Recall number

Z-0317-2027

Official notice

2026-11-11

The hazard

Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Other

UDI-DI 10711234103012

Event Ids

99863

Recall Numbers

Z-0317-2027

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103

Units affected

28,710

Hazard

Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Affected area 2

CN · China

Affected area 3

CO · Colombia

Company & contacts

Manufacturer

Accriva Diagnostics, Inc.

Phone

Not provided

Brand: Accriva Diagnostics. Contact: Accriva Diagnostics, Inc..

Source & status

Source

Tier

official

Category

Tech & Electronics

Official classification

Class II

Recall details

Recall number

Z-0317-2027

Event ID

99863

Units affected

28,710

Status

active

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 11 Nov 2026. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button